Treatment of Peripheral T-Cell Lymphoma in Community Settings.
CONCLUSIONS: The significant variability in treatments used for PTCL emphasizes the lack of consensus therapy in this rarer lymphoma and calls for additional organized prospective and registry studies to evaluate comparative effectiveness.
PMID: 28622960 [PubMed - in process]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Feldman T, Farber CM, Choi K, Faria C, Goy A, Connors J, Paramanathan D, Kaur S, Schultz E, McGuire M, Goldberg SL Tags: Clin Lymphoma Myeloma Leuk Source Type: research
More News: Cancer & Oncology | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | T-cell Lymphoma | Transplants